These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36743306)

  • 1. Polymorphisms of the
    He M; Liu M; Geng J; Liu L; Huang P; Yue M; Xia X; Zhang AM
    Front Cell Infect Microbiol; 2023; 13():1119805. PubMed ID: 36743306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms in the
    Zheng K; Shen Y; Xia X; Song Y; Zhang AM
    PeerJ; 2022; 10():e13353. PubMed ID: 35505682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population.
    Zang F; Yue M; Yao Y; Liu M; Fan H; Feng Y; Xia X; Huang P; Yu R
    Epidemiol Infect; 2018 Feb; 146(3):379-385. PubMed ID: 29271328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].
    Hu CH; Chen J; Yang R; Li NN; Yang B; Ma D; Liang XC; Wang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1307-10. PubMed ID: 23232524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of the IFNλ genes are associated with biochemical features in Han Chinese with HCV infection from Yunnan Province, China.
    Zhang AM; Ma K; Song Y; Wang B; Feng Y; Liu L; Xia X
    Infect Genet Evol; 2014 Jan; 21():161-5. PubMed ID: 24269996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.
    Zhang YY; Chen HB; Xu Y; Huang P; Wang J; Zhang Y; Yu RB; Su J
    World J Gastroenterol; 2015 Apr; 21(13):4006-13. PubMed ID: 25852288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
    Shaker OG; Abdel-Rahim MT; Bayoumi ST
    Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.
    McGilvray I; Feld JJ; Chen L; Pattullo V; Guindi M; Fischer S; Borozan I; Xie G; Selzner N; Heathcote EJ; Siminovitch K
    Gastroenterology; 2012 May; 142(5):1122-1131.e1. PubMed ID: 22285807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
    Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
    J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
    Thong VD; Wasitthankasem R; Tangkijvanich P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2015; 10(5):e0125400. PubMed ID: 25938236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China.
    Zhang AM; Zhang CL; Song Y; Zhao P; Feng Y; Wang B; Li Z; Liu L; Xia X
    Int J Infect Dis; 2016 Dec; 53():6-11. PubMed ID: 27769799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin.
    Sadeq R; Mohtady H; Al Badawy N; Ibrahim S; Omar AR; Husseiny MI; El Zowalaty M
    J Infect Dev Ctries; 2013 Nov; 7(11):859-67. PubMed ID: 24240045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
    Wu R; Chi X; Wang X; Sun H; Lv J; Gao X; Yu G; Kong F; Xu H; Hua R; Jiang J; Sun B; Zhong J; Pan Y; Niu J
    Infect Genet Evol; 2016 Apr; 39():132-140. PubMed ID: 26820907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
    Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
    Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China.
    Zhang Z; Yao Y; Wu W; Feng R; Wu Z; Cun W; Dong S
    PLoS One; 2013; 8(12):e82598. PubMed ID: 24358211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.